2026年11月4日星期三实时源已接入

ក្វាងចូវ មានពពក 30°Cអំពី

M

Meridian Globe全球版

វិបផតថលប្រមូលព័ត៌មានសកល

ព័ត៌មានបន្ទាន់

Ethics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei Asia Cyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei Asia Singapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei Asia The great yen rebalancing— 日经 Nikkei Asia Nintendo's Mario creator Miyamoto sees 'things we can do' even in AI era— 日经 Nikkei Asia North Korea leans on China and Russia to drive 3% economic growth— 日经 Nikkei Asia Japan's IHI wins key role in Westinghouse's new Poland nuclear plant— 日经 Nikkei Asia US experts warm to Japanese nuclear subs as check on China in Asian waters— 日经 Nikkei Asia Ethics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei Asia Cyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei Asia Singapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei Asia The great yen rebalancing— 日经 Nikkei Asia Nintendo's Mario creator Miyamoto sees 'things we can do' even in AI era— 日经 Nikkei Asia North Korea leans on China and Russia to drive 3% economic growth— 日经 Nikkei Asia Japan's IHI wins key role in Westinghouse's new Poland nuclear plant— 日经 Nikkei Asia US experts warm to Japanese nuclear subs as check on China in Asian waters— 日经 Nikkei Asia

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials

ប្រភព Nature 医学研究ផ្សព្វផ្សាយនៅ 02 វិច្ឆិកា 2026, 08:00 AM1 ថ្ងៃមុន

Summary

យើងផ្តល់តែសន្ទស្សន៍ចំណងជើង និងសេចក្តីសង្ខេប។ ខ្លឹមសារពេញលេញ និងសិទ្ធិអ្នកនិពន្ធ ជាកម្មសិទ្ធិរបស់ប្រភពដើម — សូមចុចតំណដើមដើម្បីអាន។

បើកឯកសារដើម

ផ្នែកព័ត៌មាន: Health
តំបន់: Global
Language: English
Item ID: health-00a74bed

Comments 0 comments

No comments yet. Be the first.

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials · Meridian Globe